MedPlast, Inc. is a global provider of vertically-integrated custom plastic processing solutions for medical devices and healthcare applications. The contract manufacturer creates custom precision molded and extruded plastic and silicone components such as seals for harmonic scalpels, trocars, specialty syringes, surgical instrument enclosures, etc. for medical OEMs.

Harvey & Company initiated and participated in the acquisition of ATP’s Engineered Rubber and Plastics Group (“ERPG”) by a Midwest private equity fund. ATP’s ERPG and K&W Medical Specialties were combined to form MedPlast, a Tempe, Arizona-based manufacturer of precision-molded plastic and rubber components for the healthcare sector. With over 800 employees and five plants in Wisconsin, Arizona, Iowa, New Jersey, and Pennsylvania, Medplast is generating nearly $100 million in annual revenue. The deal provided a strong management with the necessary infrastructure to execute an aggressive growth strategy that will encompass organic growth and strategic add-on acquisitions.